Solanich, X.
11  Ergebnisse:
Personensuche X
?
1

Pragmatic, open-label, single-center, randomized, phase II ..:

Solanich, X. ; Antolí, A. ; Padullés, N....
Contemporary Clinical Trials Communications.  21 (2021)  - p. 100716 , 2021
 
?
2

Inhibition of SARS‐CoV‐2 replication using calcineurin inhi..:

Solanich, X. ; Padullés, N. ; Niubó, J....
Journal of Internal Medicine.  289 (2021)  6 - p. 926-927 , 2021
 
?
3

Multidisciplinary care and units for uveitis in the interna..:

Fanlo, P. ; Espinosa, G. ; Adan, A....
Revista Clínica Española (English Edition).  221 (2021)  4 - p. 221-225 , 2021
 
?
 
?
5

Autoantibodies neutralizing type I IFNs are present in ~4% ..:

Bastard, P ; Gervais, A ; Le Voyer, T...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciimmunol.abl4340.  , 2021
 
?
10

The role of 2-[18F]FDG PET/CT in Erdheim-Chester disease:

Pudis, M. ; Palomar-Muñoz, A. ; Solanich-Moreno, X....
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition).  43 (2024)  1 - p. 14-22 , 2024
 
?
11

Pragmatic, open-label, single-center, randomized, phase II ..:

X. Solanich ; A. Antolí ; N. Padullés...
http://www.sciencedirect.com/science/article/pii/S2451865421000181.  , 2021
 
1-11